The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Alopecia areata
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M., Miller, C., Silver, R. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110557 · Cited by 2,103
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Xing, L., Dai, Z., Jabbari, A., Cerise, J. E., Higgins, C. A., Gong, W., de Jong, A., Harel, S., DeStefano, G. M., Rothman, L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3645 · Cited by 987
Self-citationAnti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 915
Alkhalifah, A., Alsantali, A., Wang, E., McElwee, K. J., & Shapiro, J. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.10.032 · Cited by 732
Self-citationPaller, A. S., Tom, W. L., Lebwohl, M. G., Blumenthal, R. L., Boguniewicz, M., Call, R. S., Eichenfield, L. F., Forsha, D. W., Rees, W. C., Simpson, E. L., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.05.046 · Cited by 577
Kremer, J. M., Bloom, B. J., Breedveld, F. C., Coombs, J. H., Fletcher, M. P., Gruben, D., Krishnaswami, S., Burgos‐Vargas, R., Wilkinson, B., Zerbini, C. A. F., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24567 · Cited by 546
Ocular complications of topical, peri-ocular, and systemic corticosteroids
Carnahan, M. C., & Goldstein, D. A. (2000) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200012000-00016 · Cited by 379
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
Kennedy Crispin, M., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., Chen, J. C., Cerise, J. E., Jabbari, A., Winge, M. C. G., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89776 · Cited by 355
Self-citationTofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
Liu, L. Y., Craiglow, B. G., Dai, F., & King, B. A. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.09.007 · Cited by 349
Madani, S., & Shapiro, J. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103909 · Cited by 332
Self-citationOral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Mackay-Wiggan, J., Jabbari, A., Nguyen, N., Cerise, J. E., Clark, C., Ulerio, G., Furniss, M., Vaughan, R., Christiano, A. M., & Clynes, R. (2016) · JCI Insight · doi:10.1172/jci.insight.89790 · Cited by 297
Self-citationAlkhalifah, A., Alsantali, A., Wang, E., McElwee, K. J., & Shapiro, J. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.10.031 · Cited by 290
Self-citationTofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy
Craiglow, B. G., & King, B. A. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.1520 · Cited by 259
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
Jabbari, A., Dai, Z., Xing, L., Cerise, J. E., Ramot, Y., Berkun, Y., Sanchez, G. A. M., Goldbach-Mansky, R., Christiano, A. M., Clynes, R., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.02.015 · Cited by 233
Self-citationCraiglow, B. G., & King, B. A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.260 · Cited by 223
Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
Levy, L. L., Urban, J., & King, B. A. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.06.045 · Cited by 216
Ports, W. C., Khan, S., Lan, S., Lamba, M., Bolduc, C., Bissonnette, R., & Papp, K. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12266 · Cited by 204
Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis
Tosti, A., Piraccini, B. M., Pazzaglia, M., & Vincenzi, C. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.423 · Cited by 181
Tofacitinib for the treatment of alopecia areata and variants in adolescents
Craiglow, B. G., Liu, L. Y., & King, B. A. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.09.006 · Cited by 179
Blume-Peytavi, U., Hillmann, K., Dietz, E., Canfield, D., & Garcia Bartels, N. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.09.724 · Cited by 175
Higgins, E., Al Shehri, T., McAleer, M. A., Conlon, N., Feighery, C., Lilic, D., & Irvine, A. D. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1867 · Cited by 173
Efficacy of topical sensitizers in the treatment of alopecia areata
Rokhsar, C. K., Shupack, J. L., Vafai, J. J., & Washenik, K. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70048-9 · Cited by 142
Tosti, A., Iorizzo, M., Botta, G. L., & Milani, M. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01781.x · Cited by 135
Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata
Price, V. H. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70095-4 · Cited by 134
Topical Ruxolitinib for the Treatment of Alopecia Universalis
Craiglow, B. G., Tavares, D., & King, B. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.4445 · Cited by 120
Strober, B. E., Buonanno, M., Clark, J. D., Kawabata, T. T., Tan, H., Wolk, R. A., Valdez, H., Langley, R. G. B., Harness, J. A., Menter, A., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12517 · Cited by 99
Assay of 0.2 % Fluocinolone Acetonide Cream for Alopecia Areata and Totalis
Pascher, F., Kurtin, S. B., & Andrade, R. (2009) · Dermatologica · doi:10.1159/000252466 · Cited by 77
Chu, T. W., AlJasser, M. I., Alharbi, A. H. S., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.049 · Cited by 69
Ohlmeier, M., Traupe, H., Luger, T., & Böhm, M. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04114.x · Cited by 63
Ruxolitinib‐induced reversal of alopecia universalis in a patient with essential thrombocythemia
Pieri, L., Guglielmelli, P., & Vannucchi, A. M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23871 · Cited by 63
Efficacy of tofacitinib in treatment of alopecia universalis in two patients
Gupta, A. K., Carviel, J., & Abramovits, W. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13598 · Cited by 61
Chartaux, E., & Joly, P. (2010) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2010.06.031 · Cited by 50
Cited by
Two Phase 3 Trials of Baricitinib for Alopecia Areata
King, B., Ohyama, M., Kwon, O., Zlotogorski, A., Ko, J., Mesinkovska, N. A., Hordinsky, M., Dutronc, Y., Wu, W.-S., McCollam, J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2110343 · Cited by 506
Minoxidil and its use in hair disorders: a review
Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019) · Drug Design, Development and Therapy · doi:10.2147/dddt.s214907 · Cited by 451
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
Zhou, C., Li, X., Wang, C., & Zhang, J. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08883-0 · Cited by 393
T cells and the skin: from protective immunity to inflammatory skin disorders
Ho, A. W., & Kupper, T. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0162-3 · Cited by 241
Metadata
- Authors
- Strazzulla, L. C., Wang, E. H. C., Avila, L., Lo Sicco, K., Brinster, N., Christiano, A. M., & Shapiro, J.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 78
- Issue
- 1
- Pages
- 15-24
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2773759136
- Cited by
- 263
- References
- 33
- FWCI
- 21.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.